English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16830/19259 (87%)
Visitors : 7099916      Online Users : 792
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/27620


    標題: ECSTASY, an adjustable membrane-tethered/soluble protein expression system for the directed evolution of mammalian proteins
    作者: Chen, Cheng-Pao
    Hsieh, Yuan-Ting
    Prijovich, Zeljko M.
    Chuang, Huai-Yao
    Chen, Kai-Chuan
    Lu, Wei-Cheng
    Tseng, Qingzong
    Leu, Yu-Lin
    Cheng, Tian-Lu
    Roffler, Steve R.
    貢獻者: 藥學系
    關鍵字: Beta-Glucuronidase
    Directed Evolution
    Gpi Anchor
    High-Throughput Screening
    Mammalian Cell Surface Display
    日期: 2012-07
    上傳時間: 2014-03-21 16:15:30 (UTC+8)
    出版者: Oxford Univ Press
    摘要: We describe an adjustable membrane-tethered/soluble protein screening methodology termed ECSTASY (enzyme cleavable surface tethered all-purpose screening system) which combines the power of high-throughput fluorescence-activated cell sorting of membrane-tethered proteins with the flexibility of soluble assays for isolation of improved mammalian recombinant proteins. In this approach, retroviral transduction is employed to stably tether a library of protein variants on the surface of mammalian cells via a glycosyl phosphatidylinositol anchor. High-throughput fluorescence-activated cell sorting is used to array cells expressing properly folded and/or active protein variants on their surface into micro-titer culture plates. After culture to expand individual clones, treatment of cells with phosphatidylinositol-phospholipase C releases soluble protein variants for multiplex measurement of protein concentration, activity and/or function. We utilized ECSTASY to rapidly generate human beta-glucuronidase variants for cancer therapy by antibody-directed enzyme prodrug therapy with up to 30-fold greater potency to catalyze the hydrolysis of the clinically relevant camptothecin anti-cancer prodrug as compared with wild-type human beta-glucuronidase. A variety of recombinant proteins could be adjustably displayed on fibroblasts, suggesting that ECSTASY represents a general, simple and versatile methodology for high-throughput screening to accelerate sequence activity-based evolution of mammalian proteins.
    Appears in Collections:[藥學系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML355View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback